Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 278

1.

Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study.

Uchida T, Baba S, Irie A, Soh S, Masumori N, Tsukamoto T, Nakatsu H, Fujimoto H, Kakizoe T, Ueda T, Ichikawa T, Ohta N, Kitamura T, Sumitomo M, Hayakawa M, Aoyagi T, Tachibana M, Ikeda R, Suzuki K, Tsuru N, Suzuki K, Ozono S, Fujimoto K, Hirao Y, Monden K, Nasu Y, Kumon H, Nishi K, Ueda S, Koga H, Naitoh S.

Hinyokika Kiyo. 2005 Oct;51(10):651-8.

2.

Treatment of localized prostate cancer using high-intensity focused ultrasound.

Uchida T, Ohkusa H, Nagata Y, Hyodo T, Satoh T, Irie A.

BJU Int. 2006 Jan;97(1):56-61.

3.

High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience.

Blana A, Walter B, Rogenhofer S, Wieland WF.

Urology. 2004 Feb;63(2):297-300. Review.

PMID:
14972475
4.

High-intensity focused ultrasound therapy for clinically localized prostate cancer.

Lee HM, Hong JH, Choi HY.

Prostate Cancer Prostatic Dis. 2006;9(4):439-43. Epub 2006 Jul 18.

PMID:
16847468
5.

[Transrectal high-intensity focused ultrasound with the Sonablate 500 for the treatment of prostate cancer].

Lu J, Chen ZY, Wang W, Zhang YF, Qiu XF, Zhang LC, Hu WL, Xu WF, Ye ZQ.

Zhonghua Nan Ke Xue. 2007 Nov;13(11):1005-8. Chinese.

PMID:
18077913
6.

Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience.

Uchida T, Shoji S, Nakano M, Hongo S, Nitta M, Murota A, Nagata Y.

Int J Urol. 2009 Nov;16(11):881-6. doi: 10.1111/j.1442-2042.2009.02389.x.

7.

[High-intensity focused ultrasound for localized prostate cancer].

Uchida T.

Nihon Rinsho. 2005 Feb;63(2):345-9. Japanese.

PMID:
15714990
8.

High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure.

Blana A, Brown SC, Chaussy C, Conti GN, Eastham JA, Ganzer R, Murat FJ, Pasticier G, Rebillard X, Rewcastle JC, Robertson CN, Thuroff S, Ward JF.

BJU Int. 2009 Oct;104(8):1058-62. doi: 10.1111/j.1464-410X.2009.08518.x. Epub 2009 Apr 17.

9.

[Results of transrectal focused ultrasound for the treatment of localized prostate cancer (120 patients with PSA < or + 10ng/ml].

Poissonnier L, Gelet A, Chapelon JY, Bouvier R, Rouviere O, Pangaud C, Lyonnet D, Dubernard JM.

Prog Urol. 2003 Feb;13(1):60-72. French.

PMID:
12703356
10.

High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology.

Rebillard X, SouliƩ M, Chartier-Kastler E, Davin JL, Mignard JP, Moreau JL, Coulange C; Association Francaise d'Urologie.

BJU Int. 2008 May;101(10):1205-13. doi: 10.1111/j.1464-410X.2008.07504.x. Epub 2008 Mar 4. Review.

11.

Transrectal high-intensity focused ultrasound for treatment of localized prostate cancer.

Inoue Y, Goto K, Hayashi T, Hayashi M.

Int J Urol. 2011 May;18(5):358-62. doi: 10.1111/j.1442-2042.2011.02739.x. Epub 2011 Mar 30.

12.

Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes.

Pfeiffer D, Berger J, Gross AJ.

BJU Int. 2012 Dec;110(11):1702-7. doi: 10.1111/j.1464-410X.2012.11375.x. Epub 2012 Aug 29.

13.
14.

High Intensity Focused Ultrasound (HIFU): a useful alternative choice in prostate cancer treatment. Preliminary results.

Maestroni U, Ziveri M, Azzolini N, Dinale F, Ziglioli F, Campaniello G, Frattini A, Ferretti S.

Acta Biomed. 2008 Dec;79(3):211-6.

PMID:
19260381
15.

[Transurethral resection of prostate just following high intensity focused ultrasound in localized prostate cancer--trial for early removal of the urethral catheter].

Otsuki H, Sumitomo M, Umeda S, Shirotake S, Tobe M, Ito K, Asano T, Nagakura K, Hayakawa M.

Hinyokika Kiyo. 2008 Mar;54(3):189-95. Japanese.

17.

Endorectal magnetic resonance imaging and magnetic resonance spectroscopy to monitor the prostate for residual disease or local cancer recurrence after transrectal high-intensity focused ultrasound.

Cirillo S, Petracchini M, D'Urso L, Dellamonica P, Illing R, Regge D, Muto G.

BJU Int. 2008 Aug;102(4):452-8. doi: 10.1111/j.1464-410X.2008.07633.x. Epub 2008 May 12.

18.

PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer.

Ganzer R, Rogenhofer S, Walter B, Lunz JC, Schostak M, Wieland WF, Blana A.

Eur Urol. 2008 Mar;53(3):547-53. Epub 2007 Jul 17.

PMID:
17662520
19.

Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results.

Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y.

J Urol. 1999 Jan;161(1):156-62.

PMID:
10037389
20.

High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up.

Challacombe BJ, Murphy DG, Zakri R, Cahill DJ.

BJU Int. 2009 Jul;104(2):200-4. doi: 10.1111/j.1464-410X.2009.08355.x. Epub 2009 Feb 11.

Supplemental Content

Support Center